tiprankstipranks
Ultragenyx Reports Strong Q3 Growth and Milestones
PremiumCompany AnnouncementsUltragenyx Reports Strong Q3 Growth and Milestones
20d ago
Ultragenyx reports Q3 EPS ($1.40), consensus ($1.45)
Premium
The Fly
Ultragenyx reports Q3 EPS ($1.40), consensus ($1.45)
21d ago
Ultragenyx backs FY24 revenue view $530M-$550M, consensus $536.8M
Premium
The Fly
Ultragenyx backs FY24 revenue view $530M-$550M, consensus $536.8M
21d ago
Inozyme appoints Erik Harris to board of directors
PremiumThe FlyInozyme appoints Erik Harris to board of directors
2M ago
Ultragenyx receives Breakthrough Therapy Designation for setrusumab
Premium
The Fly
Ultragenyx receives Breakthrough Therapy Designation for setrusumab
2M ago
Ultragenyx provides update on Cyprus2+ study, to submit protocol amendment
Premium
The Fly
Ultragenyx provides update on Cyprus2+ study, to submit protocol amendment
2M ago
Ultragenyx price target lowered to $81 from $83 at Barclays
PremiumThe FlyUltragenyx price target lowered to $81 from $83 at Barclays
4M ago
Top Stock Gainers Today – TNDM, TWLO, and More
Premium
Market News
Top Stock Gainers Today – TNDM, TWLO, and More
4M ago
3 Best Stocks to Buy Now, 8/2/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 8/2/2024, According to Top Analysts 
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100